Hagerman, Allison

Insider profile

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return 988% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Hagerman, Allison's trades of Oncolytics Biotech Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-13 2026-02-12 B Purchase
86,883 +11.1%
71.08
US$2,548,907
86,883 +11.1% 71.08 US$2,548,907
2025-07-18 2025-07-17 B Purchase
65,399 -10.2%
216.97
CA$4,592,638
65,399 -10.2% 216.97 CA$4,592,638